Zobrazeno 1 - 10
of 75
pro vyhledávání: '"Andrea Lissoni"'
Publikováno v:
Ricerche di S/Confine, Vol Dossier 7, Pp 114-115 (2022)
La conversazione è incentrata sul ruolo delle istituzioni culturali durante il periodo pandemico e post-pandemico. Quale approccio hanno avuto, e avranno, le istituzioni della memoria alla sfera digitale? Quale è l'apporto del digitale alle istituz
Externí odkaz:
https://doaj.org/article/eab3e43d67da4119b58bee2e17f4f8a2
Autor:
Francesco Perrone, Ugo De Giorgi, Maria Carmela Piccirillo, Annamaria Ferrero, Andrea Lissoni, Mariateresa Lapresa, Laura Arenare, Giorgio Bogani, Nicoletta Colombo, Daniela Califano, Angiolo Gadducci, Enrico Breda, Raimondo Di Liello, Giovanni Scambia, Andrea De Censi, Gennaro Daniele, Piera Gargiulo, Sandro Pignata, Paolo Scollo, Ciro Gallo, Margherita Nardin, Saverio Cinieri, Rossella Lauria, Francesco Raspagliesi, Vanda Salutari, Simona Frezzini, Carmela Pisano, Stefano Greggi, Domenica Lorusso, G. Artioli, Mariagrazia Distefano, Sabrina Chiara Cecere, Dionyssios Katsaros, Germana Tognon, Clorinda Schettino
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 31(10)
IntroductionThe use of routine antithrombotic prophylaxis is not recommended for advanced cancer patients receiving chemotherapy. The effect of bevacizumab-containing therapy on the risk of thromboembolic events remains controversial in ovarian cance
Autor:
Fabio Landoni, Anna Maria Ferrero, Daniela Giuliani, Stefania Cosio, Andrea Lissoni, Angiolo Gadducci
Publikováno v:
Anticancer Research. 39:2513-2517
Background/aim The aim of the study was to assess the clinical outcome of patients with malignant transformation of an ovarian mature teratoma. Patients and methods This study was conducted on 23 patients who underwent primary surgery at three Italia
Autor:
Tommaso Grassi, Maria Grazia Valsecchi, Alessandro Buda, Maria Lamanna, Martina Delle Marchette, Federica Sina, Fabio Landoni, Robert Fruscio, Cristina Bonazzi, Tommaso Bianchi, Daniela Giuliani, Lorenzo Ceppi, Anita Andreano, Andrea Lissoni
Publikováno v:
European Journal of Cancer. 111:61-68
Background: Even if borderline ovarian tumours (BOTs) in young women treated with fertility-sparing treatment (FST) have an excellent outcome, the type of surgery might affect relapse and fertility. We investigated the effect of surgical approach (op
Autor:
Carien L. Creutzberg, Petronella B. Ottevanger, Annamaria Ferrero, Luis Souhami, Pearly Khaw, GH Westerveld, Diane Provencher, Gillian Thomas, Jan Pyman, V. Do, Annerie Slot, C Davidson, G. Wilson, Stephanie M. de Boer, Peter Hoskin, C M McLachlin, Michael A. Quinn, Deborah Gregory, Remi A. Nout, Hans W. Nijman, J.J. Jobsen, Tanja C. Stam, Vincent T.H.B.M. Smit, K Whitmarsh, Paul Bessette, Roy F.P.M. Kruitwagen, W Taylor, Dionyssios Katsaros, Chantal Hanzen, Henry C Kitchener, M McCormack, Prafull Ghatage, Dominique Berton-Rigaud, J.W.M. Mens, Melanie E Powell, Elisabeth Pras, Jonathan A. Ledermann, Karen W Verhoeven-Adema, Harmen Hollema, Andrea Lissoni, Linda Mileshkin, Anjana Anand, Amanda Feeney, Sergio Gribaudo, Marie-Helene Baron, R Allerton, Hein Putter, Colin D. Johnson, P. Symonds, Ina M. Jürgenliemk-Schulz, Romerai D'Amico, Ilka Kolodziej, M Adusumalli, Naveena Singh, G Artioli, An Snyers, R Wade, Christine Haie-Meder, Roldano Fossati, Nicole Tubiana-Mathieu, Anthony Fyles, Silvestro Carinelli, Anne Capp, Alexandra J. Stewart, Kaj De Winter, B. van Triest, L.C.H.W. Lutgens, Susan Brooks, E. Van der Steen-Banasik, Pierre Duvillard, Pvc Rittenberg, Alessandro Colombo
Publikováno v:
Lancet Oncology, 20, 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
Lancet oncology, 20(9), 1273-1285. Elsevier Science
The Lancet Oncology, 20(9), 1273-1285
PORTEC study group 2019, ' Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3) : patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial ', The Lancet Oncology, vol. 20, no. 9, pp. 1273-1285 . https://doi.org/10.1016/S1470-2045(19)30395-X
The Lancet Oncology
Lancet Oncology, 20(9), 1273-1285. ELSEVIER SCIENCE INC
Lancet Oncology, 20, 9, pp. 1273-1285
BACKGROUND:The PORTEC-3 trial investigated the benefit of combined adjuvant chemotherapy and radiotherapy versus pelvic radiotherapy alone for women with high-risk endometrial cancer. We updated the analysis to investigate patterns of recurrence and
Autor:
Ina M. Jürgenliemk-Schulz, Ludy C.H.W. Lutgens, Marie Helene Baron, V. Do, Karen W Verhoeven-Adema, C. Post, Nelleke Ottevanger, Carien L. Creutzberg, Christine Haie-Meder, Jonathan A. Ledermann, Susan Brooks, Geraldine Goss, Linda Mileshkin, Anthony Fyles, Paul Bessette, Melanie E Powell, Roldano Fossati, Mary McCormack, Stephanie M. de Boer, Henry C Kitchener, Andrea Lissoni, Alexandra Leary, Vincent T.H.B.M. Smit, Romerai D'Amico, Amanda Feeney, Dionyssios Katsaros, Remi A. Nout, Hans W. Nijman, Hein Putter, Prafull Ghatage, Pearly Khaw
Publikováno v:
International Journal of Radiation Oncology-Biology-Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
International Journal of Radiation Oncology, Biology, Physics, 109, 975-986
International Journal of Radiation Oncology Biology Physics, 109(4), 975-986. Elsevier Science
International Journal of Radiation Oncology, Biology, Physics, 109(4), 975-986. ELSEVIER SCIENCE INC
International Journal of Radiation Oncology, Biology, Physics, 109, 4, pp. 975-986
International journal of radiation oncology, biology, physics, 109(4), 975-986. Elsevier
Contains fulltext : 232064.pdf (Publisher’s version ) (Open Access) PURPOSE: The survival results of the PORTEC-3 trial showed a significant improvement in both overall and failure-free survival with chemoradiation therapy versus pelvic radiation t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2798f409593ab83be7f21b7d7f100a58
http://www.redjournal.org/article/S0360301620344473/pdf
http://www.redjournal.org/article/S0360301620344473/pdf
Autor:
Eugenio Gautiero, Serena Redaelli, Marialuisa Lavitrano, Angela Bentivegna, Fabio Landoni, Gaia Roversi, Donatella Conconi, Patrizia Perego, Elena Sala, Andrea Lissoni, Leda Dalprà, Mariachiara Paderno, Chiara Cilibrasi
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 1580, p 1580 (2021)
Volume 22
Issue 4
International Journal of Molecular Sciences, Vol 22, Iss 1580, p 1580 (2021)
Volume 22
Issue 4
Uterine smooth muscle tumors of uncertain malignant potential (STUMPs) represent a heterogeneous group of tumors that cannot be histologically diagnosed as unequivocally benign or malignant. For this reason, many authors are working to obtain a bette
Autor:
Stefania Cosio, Fabio Landoni, Andrea Lissoni, Maria Letizia Di Meo, Giampaolo Di Martino, Angiolo Gadducci, Debora Ferrari
Background/aim The role of neoadjuvant chemotherapy (NACT) is under investigation in locally advanced cervical cancer (LACC). Patients and methods A total of 49 patients with FIGO stage IB1-IIB cervical cancer who underwent two different regimens of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e432f5181e12a827cc5dd566647cee
http://hdl.handle.net/11568/1121671
http://hdl.handle.net/11568/1121671
Publikováno v:
Poster.
Introduction About one third of vulvar carcinoma is diagnosed at an advanced stage and is either surgically unresectable or require pelvic exenteration. Neoadjuvant chemotherapy (NACT) has been introduced to reduce surgical invasivity. In this case s
Autor:
Giovanni Aletti, Robert Fruscio, Tommaso Grassi, Lorenzo Ceppi, Cristina Bonazzi, Marco Adorni, Nicoletta Colombo, Alessandro Buda, Fabio Landoni, Andrea Lissoni, Francesca Galli, Annalisa Garbi
Publikováno v:
Gynecologic oncology. 160(1)
Objective advanced stage clear cell ovarian cancer (CCOC) carries a higher risk of relapse and death compared to other histological subtypes. The prognosis of early-stage CCOC is controversial. Methods Early-stage high-grade OC patients from two Ital